Evercore ISI analyst Robert Ottenstein lowered the firm’s price target on Colgate-Palmolive (CL) to $94 from $100 and keeps an Outperform rating on the shares. Trading at a 20-year low relative to Staples, Colgate is “currently oversold,” but showing resilience by modestly outperforming the sector despite a recent sales miss, the analyst tells investors in a post-earnings note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive price target lowered to $87 from $96 at Morgan Stanley
- Colgate-Palmolive price target lowered to $95 from $105 at Citi
- Colgate-Palmolive price target lowered to $77 from $80 at Wells Fargo
- Midday Fly By: Apple, Amazon upbeat reports lift Nasdaq
- Morning Movers: Brighthouse Financial surges after take-private deal report